| |
| |
|
| Insider
Information: |
Skarpelos Athanasios |
| Relationship: |
Director |
| City: |
Geneva |
| State: |
V8 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,306,458 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,865,996 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,306,458 |
|
|
| Total
Value |
$5,865,996 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 14.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anavex Life Sciences Corp |
AVXL |
Director |
2022-05-25 |
1,306,458 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVXL |
Anavex Life Sciences Corp |
Director |
– • – |
2022-05-25 |
4 |
S |
$9.06 |
$453,000 |
D/D |
(50,000) |
1,306,458 |
0 |
% |
|
| AVXL |
Anavex Life Sciences Corp |
Director |
– • – |
2022-05-25 |
4 |
OE |
$0.92 |
$46,000 |
D/D |
50,000 |
1,356,458 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
Director |
– • • |
2013-11-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
300,000 |
5,225,832 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
Director |
– • • |
2013-10-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
200,000 |
5,525,832 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
Director |
– • • |
2013-10-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000,000 |
5,725,832 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
10% Owner |
– – • |
2009-10-29 |
4 |
S |
$2.25 |
$250,002 |
D/D |
(111,112) |
6,725,832 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
10% Owner |
– – • |
2009-08-08 |
4 |
S |
$2.25 |
$250,002 |
D/D |
(111,112) |
6,836,944 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
10% Owner |
– – • |
2009-06-29 |
4 |
S |
$2.25 |
$1,393,749 |
D/D |
(619,444) |
6,948,056 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
10% Owner |
– – • |
2007-10-26 |
4 |
S |
$1.70 |
$1,615,000 |
D/D |
(950,000) |
7,567,500 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
10% Owner |
– – • |
2007-09-17 |
4 |
B |
$3.60 |
$333,000 |
D/D |
92,500 |
8,517,500 |
2.45 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
10% Owner |
– – • |
2007-07-30 |
4 |
S |
$1.70 |
$1,615,000 |
D/D |
(950,000) |
8,425,000 |
0 |
- |
|
| AVXL |
Anavex Life Sciences Corp |
10% Owner |
– – • |
2006-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,812,500 |
9,375,000 |
|
- |
|
| AVXL |
Anavex Life Sciences Corp |
10% Owner |
– – • |
2006-04-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,562,500 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
